MASSACHUSETTS
BIOMEDICAL
INITIATIVES

MBI is the longest-running life sciences incubator in the Commonwealth. We help emerging life sciences companies advance from concept to clinical trials, create jobs, and promote economic development.

Incubate

We help emerging life sciences companies advance from concept to clinical trials so they can bring lifesaving products to patients

Companies

Since 2000, MBI has incubated over 188 companies that have created over 1,800 jobs and raised over $1.4 billion

Cluster Building

We support economic and workforce development to create a sustainable ecosystem in Massachusetts

Success Stories

TransCode Therapeutics

A platform delivery company focusing on oncology, TransCode launched clinical trials while at MBI. The team closed a $30M IPO event while at our incubator and announced an additional $7M IPO shortly after graduating in 2023.

iVexSol

iVexSol, whose mission is to improve patients' lives by developing transformative vector production technologies, graduated from MBI in 2022 with 20+ employees and has raised $40M to date.

Invetx

A veterinary therapeutics company focused on biopharmaceuticals that bring the best of human biotechnology to animal health, Invetx graduated from MBI in 2022 and has raised over $80M+.

79%

Graduate company success rate

188+

Successful MBI Graduate Companies

1801+

Total jobs created

$1.9B+

Cumulative economic impact

Ready to start your company?

featured news

Press Release: Governor Healey Visits MBI

March 11, 2024 / Press Release

“MBI is an incredible gem and institution for our state.....The innovation happening here is at the heart of our vision.” - Massachusetts Governor Maura Healey

More

MBI, Venture Forum Launch Spark Mentorship to Support Life Science Entrepreneurs

February 5, 2024 / Press Release

MBI and Venture Forum have launched "Spark," a new, 8-week long mentorship program for early-stage life science entrepreneurs.

More

latest updates

MBI’s 2023 Impact Report

April 9, 2024 / Press Release

Check out MBI's 2023 Impact Report

More

Regulatory Roadmap – Lunch & Learn

March 11, 2024 / Event

Join us for a lunch & learn session where we'll navigate life science startup compliance together!

More